Drug Coated Balloon Market Analysis | United States | 2020-2026 | MedCore
- Year: 2018
- Scope: 2014-2024
- Region: United States
- Pages: 524
- Published Date: 4/1/2018
- Type: MedCore
The value of the SFA DCB market has increased rapidly since launching in late-2014. However, the market is expected to contract in 2018, following the expiration of the transitional pass-through payment (TPT) on December 31, 2017. As of January 1st 2018, the cost of DCBs has been packaged into payments for associated procedures. As a result, plain-old balloon angioplasty (POBA) and DCB procedures are reimbursed at the same rate. The lack of reimbursement will price some accounts out of the DCB market, limiting access to DCB technology and causing DCB unit sales to decline.
Drug-coated balloons have emerged as a promising technology for treating peripheral arterial disease (PAD). These devices are similar to traditional balloon dilation catheters, but feature a drug coating designed to combat restenosis
Segments Covered in This Market
- Drug Coated Balloon Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Companies Analyzed
Of the companies in the US drug coated balloon market, Medtronic is the leading competitor, followed by C. R. Bard and Philips. A contributing factor to Medtronic’s leading position in their market is that they offer the IN.PACT Admiral™ Paclitaxel-coated PTA Balloon Catheter.
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled U.S. Market Report Suite for Peripheral Vascular Devices – MedSuite
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Drug Coated Balloon Market Analysis | United States | 2020-2026 | MedCore
$295 – $5,995
Drug-coated balloons have emerged as a promising technology for treating peripheral arterial disease (PAD). These devices are similar to traditional balloon dilation catheters, but feature a drug coating designed to combat restenosis. As of January 2018, DCBs are approved in the United States for use in treating lesions of the superficial femoral artery (SFA) and in AV access procedures. However, several companies are in the process of obtaining approval for BTK use of DCBs.
- 2018
- 2014-2024
- United States
- 4/1/2018
- 524
- MedCore
Related Reports
